Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Mar
21
2023
“Made with Real Milk” (Fat?) Lawsuit Dismissed Keller and Heckman LLP
Mar
21
2023
EUON Posts Nanopinions on Graphene Electronic Tattoos and How to Monitor the Crystal Defect Structure in Nanomaterials Bergeson & Campbell, P.C.
Mar
21
2023
The Georgia Supreme Court Should Reconsider Allowing Lawyers to Represent Clients Following Georgia Law Bradley Arant Boult Cummings LLP
Mar
20
2023
Is “French Dessert” Necessarily Made in France? Keller and Heckman LLP
Mar
20
2023
FDA Draft Guidance Signifies Acceptance of the Term “Milk” to Describe Plant-Based Alternatives Sheppard, Mullin, Richter & Hampton LLP
Mar
20
2023
FDA Modernizes Mammography Regulations, Provides Facilities with Eighteen-Month Compliance Deadline Mintz
Mar
20
2023
Pennsylvania Commonwealth Court Holds Employer Financially Responsible for Employee’s Medical Marijuana Treatment Wilson Elser Moskowitz Edelman & Dicker LLP
Mar
17
2023
DOJ Files FCA Complaint Against Major Pharmacy Retailer Based on Alleged Violations of Controlled Substances Act ArentFox Schiff LLP
Mar
17
2023
Access to Mifepristone Hangs in the Balance ArentFox Schiff LLP
Mar
16
2023
JEMRA Makes Campylobacter Prevention Recommendations Keller and Heckman LLP
Mar
16
2023
The Fondues and Don’ts of Certification Marks McDermott Will & Emery
Mar
16
2023
FCC Announces March 28 Meeting of Precision Agriculture Connectivity Task Force ArentFox Schiff LLP
Mar
16
2023
As COVID-19 Emergency Waivers End, DEA Proposes to Expand Tele-Prescribing of Controlled Substances Robinson & Cole LLP
Mar
16
2023
AG Garland Signals That Department of Justice's Cannabis Policy Will Be "Very Close" To Cole Memorandum Mintz
Mar
15
2023
CMS Releases First Set of Part B Rebatable Drugs for Coinsurance Adjustment Under IRA Sheppard, Mullin, Richter & Hampton LLP
Mar
15
2023
Chocolate Manufacturer Responds to Consumer Class Action for Heavy Metals Keller and Heckman LLP
Mar
15
2023
Personalized Medicine at FDA: The Scope & Significance of Progress in 2022 Foley & Lardner LLP
Mar
15
2023
Ch-ch-ch-ch-changes – Mississippi Legislature Makes Key Amendments to Medical Cannabis Act Bradley Arant Boult Cummings LLP
Mar
14
2023
The AI Search Engine Doctor Is Always In: What Are the Regulatory and Legal Implications? Mintz
Mar
14
2023
FDA Introduces Dietary Supplement Ingredient Directory Epstein Becker & Green, P.C.
Mar
14
2023
DEA Issues Proposed Rule for Prescribing of Controlled Substances via Telemedicine Bradley Arant Boult Cummings LLP
Mar
14
2023
Food Hall Fever: Business & Legal Considerations for Owners, Operators & Vendors ArentFox Schiff LLP
Mar
14
2023
Insufficiently Specific Pleadings Doom “Naturally Flavored” Lawsuit Keller and Heckman LLP
Mar
14
2023
Insurance Options for Cannabis Businesses Slowly Improving Bradley Arant Boult Cummings LLP
Mar
13
2023
FDA Publishes Proposed Rule on Tobacco Product Manufacturing Practices Keller and Heckman LLP
Mar
13
2023
Alabama Medical Cannabis Commission Set for Key April Votes Bradley Arant Boult Cummings LLP
Mar
13
2023
Status of FDA’s COVID-19 Guidance Documents When Public Health Emergency Expires Keller and Heckman LLP
Mar
12
2023
Washington State Based Business Offered USDA Funding to Help Increase American-Made Fertilizer Production U.S. Department of Agriculture
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins